National Cancer Institute (NCI): all 3,554 studies

Page 34 of 36. Open to participants first (334), then studies with results posted, then the rest; newest registration first within each.

• Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove PolypsCompletedNCT00005094Phase 3
• Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal CancerCompletedNCT00005085Phase 2
• 506U78 in Treating Patients With LymphomaCompletedNCT00005080Phase 2
• Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate CancerTerminatedNCT00005067Phase 1
• Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung CancerCompletedNCT00005065Phase 1
• PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic SyndromeCompletedNCT00005064Phase 1
• Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer)TerminatedNCT00005039Phase 2
• Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00005036Phase 3
• Genetic Component of HandednessCompletedNCT00005003
• Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium BacteriaCompletedNCT00004988Phase 1
• Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon CancerCompletedNCT00004931Phase 3
• Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00004919Phase 1
• Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic SyndromeCompletedNCT00004918Phase 1/2
• O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant GliomaCompletedNCT00004892Phase 1
• Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2CompletedNCT00004883Phase 2
• Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00004862Phase 1
• Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the UrotheliumTerminatedNCT00004856Phase 2
• Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive ChemotherapyCompletedNCT00004853Phase 1
• Susceptibility to Breast CancerCompletedNCT00004565
• Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma MultiformeCompletedNCT00004262Phase 1
• Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant MelanomaCompletedNCT00004244Phase 1
• Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00004242Phase 1
• 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or SarcomaCompletedNCT00004241Phase 1
• Endostatin in Treating Patients With Advanced Solid TumorsCompletedNCT00004229Phase 1
• Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced CancerCompletedNCT00004189Phase 1
• Vaccine Therapy in Treating Patients With Unresectable Metastatic MelanomaCompletedNCT00004148Phase 1
• Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00004101Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck CancerStatus unknownNCT00004097Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or LarynxStatus unknownNCT00004094Phase 2
• Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid CancerCompletedNCT00004089Phase 2
• Gene Therapy in Treating Patients With Recurrent or Progressive Brain TumorsCompletedNCT00004080Phase 1
• Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00004079Phase 1
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
• Gene Therapy Plus Chemotherapy in Treating Patients With Breast CancerCompletedNCT00004038Phase 1
• Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian CancerCompletedNCT00004032Phase 1
• Vaccine Therapy in Treating Patients With Metastatic Prostate CancerCompletedNCT00004029Phase 1
• Carmustine in Treating Patients With Recurrent Malignant GliomaCompletedNCT00004028Phase 1
• 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous LeukemiaCompletedNCT00003997Phase 1
• Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2CompletedNCT00003995Phase 2
• Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2CompletedNCT00003992Phase 2
• Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or LymphomaCompletedNCT00003970Phase 1
• Bryostatin 1 in Treating Patients With Metastatic Kidney CancerCompletedNCT00003968Phase 2
• Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic LeukemiaCompletedNCT00003934Phase 3
• Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem GliomaCompletedNCT00003909Phase 1
• Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal CancerCompletedNCT00003873Phase 3
• 4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00003853Phase 2
• Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00003850Phase 2
• 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaCompletedNCT00003837Not applicable
• Combination Chemotherapy in Treating Patients With Stage III Colon CancerCompletedNCT00003835Phase 3
• Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate CancerCompletedNCT00003832Phase 2
• Eflornithine in Treating Patients With Bladder CancerCompletedNCT00003814Phase 3
• Health-Related Outcomes in Patients Who Were Previously Treated for RhabdomyosarcomaCompletedNCT00003801Not applicable
• Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal CancerCompletedNCT00003799Phase 1
• Irofulven in Treating Patients With Metastatic Breast CancerCompletedNCT00003796Phase 2
• Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or LegCompletedNCT00003789Phase 3
• Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue SarcomaCompletedNCT00003778Phase 2
• O6-benzylguanine and Carmustine in Treating Children With Refractory CNS TumorsCompletedNCT00003765Phase 1
• Chemotherapy in Treating Children With Recurrent or Refractory SarcomasCompletedNCT00003745Phase 2
• Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic PhaseCompletedNCT00003694Phase 2
• Vaccine Therapy in Treating Patients With Stage IV MelanomaCompletedNCT00003665Phase 1
• Flavopiridol in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00003620Phase 2
• O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell LymphomaTerminatedNCT00003613Phase 1
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's LymphomaCompletedNCT00003595Phase 3
• Gene Therapy in Treating Patients With Ovarian CancerCompletedNCT00003588Phase 1
• Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's LymphomaCompletedNCT00003575Phase 2
• Vaccine Therapy in Treating Patients With MelanomaCompletedNCT00003556Phase 1
• 506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaCompletedNCT00003545Phase 2
• Raltitrexed in Treating Children With Refractory Acute LeukemiaCompletedNCT00003528Phase 1
• Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerCompletedNCT00003451Phase 1
• Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or MetastaticCompletedNCT00003440Phase 3
• Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal CancerCompletedNCT00003439Phase 1
• Irofulven in Treating Children With Recurrent or Refractory Solid TumorsCompletedNCT00003370Phase 1
• Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the PelvisCompletedNCT00003368Phase 1
• Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's SarcomaCompletedNCT00003350Phase 3
• Interleukin-12 in Treating Patients With Advanced CancerCompletedNCT00003330Phase 1
• Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid TumorsCompletedNCT00003288Phase 1
• EF5 in Treating Patients With Solid TumorsCompletedNCT00003282Phase 1
• Flavopiridol in Treating Patients With Recurrent Prostate CancerCompletedNCT00003256Phase 2
• Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced CancersCompletedNCT00003249Phase 1
• Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung CancerStatus unknownNCT00003240Phase 3
• Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's DiseaseCompletedNCT00003210Phase 2
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's LymphomaCompletedNCT00003204Phase 3
• Fenretinide in Treating Children With Solid TumorsCompletedNCT00003191Phase 1
• Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid LeukemiaCompletedNCT00003190Phase 3
• Gene Therapy in Treating Patients With Advanced Bladder CancerCompletedNCT00003167Phase 1
• Bryostatin and Vincristine in B-Cell MalignanciesCompletedNCT00003166Phase 1
• Gene Therapy in Treating Patients With Cancer of The LiverTerminatedNCT00003147Phase 1
• Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell LymphomaCompletedNCT00003039Phase 2
• 506U78 in Treating Patients With Refractory Hematologic CancerCompletedNCT00002970Phase 2
• Edrecolomab in Treating Patients With Stage II Colon CancerCompletedNCT00002968Phase 3
• Penclomedine in Treating Patients With Solid Tumors or LymphomaCompletedNCT00002946Phase 1
• Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous LeukemiaCompletedNCT00002925Phase 1/2
• Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian CancerCompletedNCT00002913Phase 1
• Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute LeukemiaCompletedNCT00002912Phase 1
• Phenylbutyrate in Treating Patients With Refractory Solid Tumors or LymphomaCompletedNCT00002909Phase 1
• Perillyl Alcohol in Treating Patients With Refractory CancerCompletedNCT00002862Phase 1
• Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung CancerCompletedNCT00002852Phase 3
• Docetaxel in Treating Children With Recurrent Solid TumorsCompletedNCT00002825Phase 2
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00002798Phase 3
• Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal CancerTerminatedNCT00002796Phase 1/2

← National Cancer Institute (NCI) overview and focus areas